BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 25655439)

  • 1. Th17 cytokines in non-melanoma skin cancer.
    McAllister F; Kolls JK
    Eur J Immunol; 2015 Mar; 45(3):692-4. PubMed ID: 25655439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-17 and interleukin-22 promote tumor progression in human nonmelanoma skin cancer.
    Nardinocchi L; Sonego G; Passarelli F; Avitabile S; Scarponi C; Failla CM; Simoni S; Albanesi C; Cavani A
    Eur J Immunol; 2015 Mar; 45(3):922-31. PubMed ID: 25487261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer-testis antigens and immunosurveillance in human cutaneous squamous cell and basal cell carcinomas.
    Walter A; Barysch MJ; Behnke S; Dziunycz P; Schmid B; Ritter E; Gnjatic S; Kristiansen G; Moch H; Knuth A; Dummer R; van den Broek M
    Clin Cancer Res; 2010 Jul; 16(14):3562-70. PubMed ID: 20519358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regression in skin tumours: a common phenomenon.
    Barnetson RS; Halliday GM
    Australas J Dermatol; 1997 Jun; 38 Suppl 1():S63-5. PubMed ID: 10994476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Melanoma and nonmelanoma skin cancers and the immune system.
    Domingo DS; Baron ED
    Adv Exp Med Biol; 2008; 624():187-202. PubMed ID: 18348457
    [No Abstract]   [Full Text] [Related]  

  • 6. The dermal cellular infiltrate and cell-mediated immunity in skin carcinomas.
    Avgerinou G; Nicolis G; Vareltzidis A; Stratigos J
    Dermatologica; 1985; 171(4):238-42. PubMed ID: 4076497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Basal cell carcinoma, squamous cell carcinoma and melanoma of the head and face.
    Feller L; Khammissa RAG; Kramer B; Altini M; Lemmer J
    Head Face Med; 2016 Feb; 12():11. PubMed ID: 26850723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunomodulatory Effectiveness of Fish Oil and omega-3 Fatty Acids in Human Non-melanoma Skin Carcinoma Cells.
    Rehman K; Mohd Amin MC; Yuen NP; Zulfakar MH
    J Oleo Sci; 2016; 65(3):217-24. PubMed ID: 26876681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spontaneous regression of human melanoma/nonmelanoma skin cancer: association with infiltrating CD4+ T cells.
    Halliday GM; Patel A; Hunt MJ; Tefany FJ; Barnetson RS
    World J Surg; 1995; 19(3):352-8. PubMed ID: 7638987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The different telomere lengths in basal and squamous cell carcinomas also differ between the nontransplant and renal transplant population.
    Perrem K; Lynch A; Al Nooh F; Leader M; Elaine Kay
    Hum Pathol; 2008 Jul; 39(7):1034-41. PubMed ID: 18482746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The immune system and skin cancer.
    Yu SH; Bordeaux JS; Baron ED
    Adv Exp Med Biol; 2014; 810():182-91. PubMed ID: 25207366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-17, IL-21, and IL-22 Cytokines of T Helper 17 Cells in Cancer.
    Nalbant A
    J Interferon Cytokine Res; 2019 Jan; 39(1):56-60. PubMed ID: 30562123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD103 negative memory T cells may play important roles in making regulatory T-cell-enriched environments in skin tumours.
    Nakamura Y; Watanabe R; Zhenjie Z; Koguchi-Yoshioka H; Vo S; Oya K; Matsumura Y; Tanaka R; Okiyama N; Ishitsuka Y; Fujimoto M; Fujisawa Y
    J Eur Acad Dermatol Venereol; 2019 May; 33(5):e211-e214. PubMed ID: 30719755
    [No Abstract]   [Full Text] [Related]  

  • 14. TGFbeta1-induced inflammation in premalignant epidermal squamous lesions requires IL-17.
    Mohammed J; Ryscavage A; Perez-Lorenzo R; Gunderson AJ; Blazanin N; Glick AB
    J Invest Dermatol; 2010 Sep; 130(9):2295-303. PubMed ID: 20410912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunotherapy for nonmelanoma skin cancer: does it have a future?
    Urosevic M; Dummer R
    Cancer; 2002 Jan; 94(2):477-85. PubMed ID: 11900233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune response associated with nonmelanoma skin cancer.
    Strickland FM; Kripke ML
    Clin Plast Surg; 1997 Oct; 24(4):637-47. PubMed ID: 9342507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced IL-18 expression in common skin tumors.
    Park H; Byun D; Kim TS; Kim YI; Kang JS; Hahm ES; Kim SH; Lee WJ; Song HK; Yoon DY; Kang CJ; Lee C; Houh D; Kim H; Cho B; Kim Y; Yang YH; Min KH; Cho DH
    Immunol Lett; 2001 Dec; 79(3):215-9. PubMed ID: 11600201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibodies to basal epidermal cells in patients with basal or squamous cell carcinoma.
    Ackermann-Schopf CM
    Arch Dermatol Res (1975); 1976 Dec; 257(2):149-56. PubMed ID: 1008612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T helper cell populations: as flexible as the skin?
    Waisman A
    Eur J Immunol; 2011 Sep; 41(9):2539-43. PubMed ID: 21952814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune response to basal cell and squamous cell carcinomas.
    Grimwood RE
    Immunol Ser; 1989; 46():789-98. PubMed ID: 2488879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.